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Background: Cardiac metastasis of renal cell carcinoma is an exceptional event, particularly when there is lack of
inferior vena cava involvement. Indeed, only a few cases have been reported worldwide thus far. Moreover,
discussion of treatment and follow-up strategies for cardiac metastasis of renal cell carcinoma is important because
of the high risk of sudden death.
Case presentation: We report the case of a 75-year-old Japanese man with metastatic tumor in the left atrium
from renal cell carcinoma. He had a history of right renal cell carcinoma, for which he had undergone hand-assisted
laparoscopic nephrectomy. Lung and bone metastases were detected after nephrectomy, and treatment with
interferon-alpha was initiated. After disease progression, he was treated concurrently with targeted molecular therapy and
radiotherapy for bone metastasis. After these therapies, a 42 × 24 mm mass was found on transthoracic echocardiography
in left atrium without involvement of the right atrium or inferior vena cava. The provisional diagnosis was metastatic mass
or myxoma, and surgical resection was performed. Histopathological examination led to a final diagnosis of metastatic
tumor from clear cell renal cell carcinoma.
Conclusion: Cardiac metastasis, metastasis to the left atrium in particular, is rare in patients with renal cell carcinoma. In
our study, surgery of the cardiac mass was effective to avoid sudden death and quality of life decline resulting from heart
failure. We describe this case and review cardiac metastasis of renal cell carcinoma.
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Renal cell carcinoma (RCC) represents about 3% of all ma-
lignant tumors. Metastasis is a strong predictors in patients
with RCC. Common sites of RCC metastasis are the lung,
lymph nodes, bone, and liver. Conversely, cardiac metasta-
sis of RCC is an exceptional event with only a few cases
reported worldwide to date, although cardiac involvement
via the inferior vena cava (IVC) thrombi is well-known.
Moreover, discussion of treatment and follow-up strategies
for cardiac metastasis of RCC is important because of the
high risk of sudden death.
Case presentation
A 75-year-old Japanese man was admitted to our
hospital in June 2010 for consciousness disturbance. After
admission, cerebral infarctions and a left atrium (LA)
mass were identified on computed tomography (CT).* Correspondence: ohba-k@nagasaki-u.ac.jp
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unless otherwise stated.He had previously been diagnosed with RCC and
had undergone hand-assisted laparoscopic nephrectomy
in October 2006 (pT2N0M0). Subsequently, multiple
lung metastases and mediastinal lymph node metastases
were detected on chest CT in April 2008. His Karnofsky
performance status score was 100, and Memorial Sloan-
Kettering Cancer Center risk classification was “favorable”.
The patient was therefore treated with three doses per
week of subcutaneous interferon-alpha at 5 million units.
However, owing to progression of lung metastases and
the appearance of a pubic bone metastasis, treatment was
changed to sorafenib at 800 mg/day in August 2009. In
January 2010, radiotherapy (total: 39 Gy in 13 fractions)
was added owing to progression and pain of the pubic
bone metastasis. At that time, sorafenib was changed to
everolimus at 10 mg/day. In July 2010, a solid mass was
found in the LA on routine CT of the lungs.
At the time of admission, vital signs were stable, with
blood pressure at 132/84 mmHg and heart rate at 64 beats/
min. Laboratory tests results indicated anemia (hemoglobin,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Chest computed tomography reveals multiple lung
metastases, but the left atrium mass is unclear.
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trocardiography revealed sinus rhythm.
Transthoracic echocardiography showed a 42 × 24 mm
mass in the LA that moved without extension into the
outflow tract (Figure 1). The right atrium and interatrial
septum appeared normal. CT of the chest and abdomen
revealed multiple metastatic tumors of the lungs, lymph
nodes and pubic bone, but no IVC involvement, and the
LA mass was unclear (Figures 2 and 3).
The appearance of the LA mass was consistent with
myxoma, but the history of RCC raised the possibility of
an intracardiac metastatic mass. Finally, the LA mass was
surgically resected to prevent sudden death from acute
heart failure or embolism resulting from tumor separation.
Although the tumor had grown into the right superior
pulmonary vein as the site of lymph node metastasis, the
mass was completely resected.
Pathological assessment of the LA tumor revealed clear
cell RCC that was diagnosed as a metastasis from the ori-
ginal RCC. After surgery, the patient did not experienced
symptom of heart disease, such as dyspnea, chest pain, or
syncope. However, multiple brain metastases were found
subsequently, and the patient died from progressive dis-
ease 4 months postoperatively.
Discussion
Cardiac metastases of RCC are rare. Actually, a study
of 266 cardiac neoplasms found in 11,432 autopsy cases
revealed just 3 cases originating of RCC [1]. Furthermore,
cardiac metastases without IVC thrombi are not common.
To the best of our knowledge, including present case, 31
reports have described cardiac metastasis of RCC withoutFigure 1 Transthoracic echocardiography shows a 42 × 24 mm left at
into the outflow tract.IVC involvement [2-12]. Therefore, we reviewed and ana-
lyzed these reports. LA metastasis appears to be particu-
larly rare, and this represents just the third report of LA
metastasis of RCC [7,8]. In the 31 reports identified, me-
tastasis to the heart alone and metastases to multiple sites
together with cardiac involvement showed comparable
frequencies (14 and 17 cases, respectively; Table 1) [2-12].
No clear difference in the frequency of laterality between
the right and left heart was evident (16 and 14 cases, re-
spectively with no bilateral cases).rium mass (indicated by arrowheads), moving without extension
Figure 3 There was no evidence of inferior vena
cava involvement.
Table 1 Summary of previous reports of cardiac
metastasis of renal cell carcinoma
Multifocality Single 14
Multiple 17








Tyrosine Kinase inhibitor 2
Unknown 9
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to be associated with absence of metastasis to other or-
gans. Conversely, left heart metastasis tended to be associ-
ated with other organ metastases, although no significant
correlation between disease side and multifocality was evi-
dent (p = 0.346) [2-12].
Cardiac metastases of RCC seem to occur through
two mechanisms. The first is a venous hematogenous
pathway through the renal vein to the right heart. In
cases with isolated disease, delayed progression to the
right heart, without involvement of the IVC, remains
the most probable mode of metastasis through venous
hematogenous microdissemination. The second mechanisminvolves a lymphatic pathway through the lymphatic ves-
sels of the thorax, involving the carinal lymph nodes and
parasternal lymph vessels. Reports have mentioned that
drainage from the left heart wall passes through these
lymph vessels, and lymphatic flow can be reversed by me-
tastasis to the nodes [4,13]. This hypothesis is supported
by the fact that disseminated disease progression involves
the supradiaphragmatic and mediastinal lymph nodes and
the lungs, and the side of the heart involved more fre-
quently is the left side.
The second mechanism of metastasis is more compat-
ible with the present case, because the left side of the
heart was affected by metastasis, the diseases was non-
isolated, and lung metastasis was present.
Malignant cardiac tumors have been managed surgi-
cally in some patients, but no general consensus has
been reached regarding treatment strategies for such
disease. For carefully selected patients, resection of car-
diac metastases has been used to provide symptom pal-
liation, improved quality of life, and prolonged survival
[14]. In recent years, Szmit et al. reported a case of heart
failure caused by heart metastases of RCC successfully
treated using receptor tyrosine kinase inhibitor [5]. In
addition, Karakiewicz et al. reported the neoadjuvant set-
ting using sunitinib to downstage an atrial thrombus [15].
Conversely, some reports have described cases of sudden
death due to cardiac metastases [2,4,16].
In cases of isolated cardiac metastasis, surgical resec-
tion seems effective and offers favorable outcomes [6,7].
In cases with metastases to multiple sites including the
heart, improvement of heart failure and prevention of
sudden death may be achieved using a combination of
surgical treatment and targeted molecular therapy.
Conclusion
We have reported a case of LA mass caused by metastatic
RCC and have reviewed previous reports on the subject.
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sudden death and decline in quality of life resulting from
heart failure.
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